Autumn Medicine Distribution Announced by Minister Warken
In a recent press conference, Health Minister Nina Warken addressed concerns about medication availability, highlighting her efforts to ensure a stable supply this fall and winter.
Minister Warken, who passed the Anti-Shortage Law (Anti-Mangelgesetz) in 2023, emphasized that drug supply has a very high priority at both the national and European levels. The law, aimed at addressing acute supply problems, has made stocks of several months' worth of commonly used medications mandatory as a safety buffer.
The reform also aims to provide pharmacies with more flexibility in medication exchanges, allowing for more flexibility in exchanging suitable available medications. However, the minister did not specify which medications or shortages the proposed measures would address.
Regarding the current supply situation for medications other than children's, Minister Warken did not provide specific details. She did mention, though, that the supply of children's medications has shown significant improvement compared to previous years.
The Health Minister also indicated a willingness to take prompt measures in case of medication shortages, but did not provide details about the timeline for the implementation of the reform.
In addition, Minister Warken addressed concerns about medication availability raised by the CDU politician. She expressed optimism about the future, predicting a stable medication supply this fall and winter.
Furthermore, EU regulations will strengthen production sites in Europe, according to the Health Minister, which she believes will contribute to a more secure medication supply.
However, the effectiveness of the Anti-Shortage Law and the proposed reform in addressing medication shortages is not specified. The Health Minister did not mention any ongoing issues with medication supply in the conference.
It's worth noting that the article does not provide any new information about the current state of the Anti-Shortage Law or the specific changes made to it since its implementation in 2023. The Health Minister did not provide details about the easing of price regulations to make medication deliveries to Germany more attractive, as stated in the original law.
In conclusion, while Minister Warken outlined her plans for ensuring a stable medication supply, specific details about the current supply situation, the medications the reform will address, and the timeline for the implementation of the reform remain unclear.
Read also:
- Parliamentary Meetings in the Federal Diet of Germany this Week
- A Meniscus Tear refers to a common knee injury that occurs when the meniscus, a crescent-shaped cartilage within the knee joint, becomes torn or damaged.
- Startupopportunities available at the European Health Congress; submissions accepted for potential collaborations
- Lockdowns fuel COVID-19 threat perception, according to recent research in the UK
